A distinct gut microbiome signature has been identified in people with IBS who are responsive to low FODMAP dietary therapy. And if confirmed in further studies, the unique gut microbiome subtypes found in IBS may be useful as a biomarker to enable clinicians to select patients who are likely to be suitable or unsuitable for ...
Microbiome signature may identify IBS patients who respond to FODMAP diet
By Michael Woodhead
23 Nov 2021